Axsome acquires Avenue's subsidiary for epilepsy drug development
Go back to Axsome acquires Avenue's subsidiary for epilepsy drug development| (NASDAQ: ATXI) | Delayed: 0.42 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.42 | 52 Week High | $ | |||
| Open | $0.42 | 52 Week Low | $ | |||
| Day High | $0.42 | P/E | N/A | |||
| Day Low | $0.42 | EPS | $ | |||
| Volume | 2,433 | |||||
| (NASDAQ: AXSM) | Delayed: 205.17 +2.34 (1.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $202.83 | 52 Week High | $15.74 | |||
| Open | $203.11 | 52 Week Low | $5.37 | |||
| Day High | $206.84 | P/E | N/A | |||
| Day Low | $201.54 | EPS | $0.00 | |||
| Volume | 179,413 | |||||
| Fabien Corp (NASDAQ: FBIO) | Delayed: 2.69 +0.01 (0.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.68 | 52 Week High | $4.66 | |||
| Open | $2.67 | 52 Week Low | $2.01 | |||
| Day High | $2.74 | P/E | N/A | |||
| Day Low | $2.67 | EPS | $0.00 | |||
| Volume | 150,390 | |||||

